A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Amygdalin Regulates FOXO3a Signaling to Inhibit Oxidative Stress and Improve Alopecia Areata in Mice

70 views

⸱

DOI:

10.3791/73759

⸱

September 29th, 2026

 ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

This study aims to explore the potential molecular mechanisms underlying amygdalin's antioxidant and anti-inflammatory effects in the alopecia areata model in C3H/HeJ mice and in a human primary epidermal melanocyte injury model induced by H2O2.

Abstract

This paper aims to explore the mechanism of amygdalin's (AMG) therapeutic effect on alopecia areata (AA). Hematoxylin-eosin staining was used to probe AMG's hepatorenal toxicity. After establishing the AA model of C3H/HeJ mice and H2O2-damaged human primary epidermal melanocytes (HPEMs), and following AMG intervention, the reactive oxygen species (ROS) content and the levels of forkhead box O3A (FOXO3a) protein and gene were monitored. Biochemical kits or ‌enzyme-linked immunosorbent assay‌ were used to detect the contents of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase 4 (GPX-4), malondialdehyde (MDA), interleukin-15 (IL-15), interferon-gamma (IFN-γ), and interleukin-6‌ (IL-6). A Western blot was performed to assess the levels of MHC I, IL-15, FOXO3a, SOD, CAT, GPX-4, IFN-γ, IL-6, and IL-15. ChIP-PCR was performed to assess the enrichment of AMG at the promoters of SOD, CAT, and GPX-4 in FOXO3a. Meanwhile, ROS, apoptosis, and the protein and gene levels of FOXO3a, SOD, CAT, and GPX-4 in HPEMs with low FOXO3a expression were investigated. AMG has no potential liver or kidney toxicity and can reduce the expression of MHC I and IL-15 proteins in skin, as well as the serum IL-15. AMG can enhance the expression of the FOXO3a protein and gene in the skin, as well as the levels of SOD, CAT, and GPX-4, while reducing ROS and MDA levels. AMG can inhibit MHC I, IFN-γ, IL-6, and IL-15, MDA, apoptosis, and ROS production in HPEMs, and increase SOD, CAT, and GPX-4 contents. Importantly, AMG can upregulate the expression of the FOXO3a, SOD, CAT, and GPX-4 genes and proteins, and enrich FOXO3a at the promoters of SOD, CAT, and GPX-4. These data suggest that AMG can promote FOXO3a expression and inhibit oxidative stress and inflammatory responses, thereby improving AA in C3H/HeJ mice.

Introduction

As an autoimmune disorder characterized by sudden, non-scarring hair loss, alopecia areata (AA) has a global prevalence of approximately 2–3%, and there are over 30 million patients in China1. Epidemiological data manifest that the disease can affect individuals across all age groups, but it exhibits a higher prevalence among young adults, with about 60% of patients experiencing their first onset before the age of 20, with a nearly equal male-to-female ratio1,2. Globally, the annual incidence of AA is approximately 0.2–0.3%, with 40% being single-site AA, 35% multi-site AA, ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Ethics approval and consent to participate
The experimental protocols involving animals were authorized by the Ethics Committee of Scientist Biotechnology Co., Ltd. (Ethical Approval Number: SYST-2024-014), following the ARRIVE 2.0, NIH Guide for the Care and Use of Laboratory Animals. And the Ethics Committee of Sichuan Provincial People’s Hospital granted approval for the ethical use of human clinical samples for in vitro experiments (Ethical Approval Number: 2024103). Informed consent was obtained from all tissue donors. All commercial details of the reagents and the equipment used in this study are provided in the Tabl....

Access restricted. Please log in or start a trial to view this content.

Results

AMG has no hepatorenal toxicity in normal C3H/HeJ mice
To clearly identify the potential liver and kidney toxicity of AMG from an experimental perspective, researchers administered the three doses (60, 90, and 120 mg/kg) previously studied in normal C3H/HeJ mice by gavage 38. As shown in Figure 1, after intragastric administration of AMG at three doses for 21 days, the architecture of the hepatic lobules was distinct, with hepatocytes arranged in an orderly manner. The.......

Access restricted. Please log in or start a trial to view this content.

Discussion

AMG itself has no direct toxicity. It is hydrolyzed by intestinal microbial enzymes or gastric acid, generating and releasing highly toxic hydrogen cyanide49. Hydrogen cyanide is then rapidly absorbed through the digestive tract into the bloodstream and spreads throughout the body tissues, causing hypoxia in the nervous system, cardiovascular system, and respiratory system tissues50. In terms of mechanism, hydrogen cyanide combines with the iron ions in cytochrome oxidase, .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no conflicts of interest to declare.

AUTHORS’ CONTRIBUTION:
Xun He: Investigation, Methodology, Writing – original draft. Jingsong Liu, Jiawei Wang, and Zhe Dai: Data curation. Yugang Gong, Wei Lu, and Xiaowei Sha: Software, Visualization, and Validation. Xun He: Conceptualization, Writing – Review & Editing, Funding acquisition, and Supervision.

Acknowledgements

This work was supported by the Sichuan Provincial Cadres Healthcare Committee (2024-221).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
5×All-In-One MasterMix (with AccuRT genomic DNA removal kit)Applied Biological Materials Inc., Jiangsu, ChinaG492
β-Actin antibodyAffinity Biosciences Co., Ltd., Wuhan, ChinaAF7018
AmygdalinChengdu Herbpurify Co., Ltd., Chengdu, ChinaK-001-181216
Catalase antibodyProteintech, Wuhan, China66765-1-Ig
Catalase kitElabscience, Wuhan, ChinaE-BC-K031-M
C3H/HeJ miceChengdu Yaokang Biotechnology Co., Ltd., Chengdu, ChinaN000190
ChIP assay kitBeyotime Biotechnology, Shanghai, ChinaP2078
254 culture mediumGibco, Thermo Fisher Scientific, AmericaM-254-500
DAPI staining reagentServicebio, Wuhan, ChinaG1012
Dispase IIShanghai Yuanye Bio-Technology Co., Ltd., Shanghai, ChinaS25046
EvaGreen Express 2×qPCR MasterMix-No DyeApplied Biological Materials Inc., Jiangsu, ChinaMasterMix-ES
Fast black HBSangon Biotech Co., Ltd., Shanghai, ChinaA602008-0025
Fetal bovine serumEvery Green13011-8611
Fluorescence microscopeSOPTOPCX40
FOXO3a antibodyProteintech, Wuhan, China10849-1-AP
Freezing microtomeThermoCryotome E
Glutathione peroxidase 4 antibodyProteintech, Wuhan, China67763-1-Ig
Glutathione peroxidase 4 kitElabscience, Wuhan, ChinaE-BC-K883-M
Image-pro plus 6.0Media Cybernetics, Inc., Rockville, MD, USA——
Imiquimod creamSichuan Mingxin Pharmaceutical Co. Ltd., Chengdu, ChinaH20030129
Interferon gamma antibodyProteintech, Wuhan, China15365-1-AP
Interferon gamma kitElabscience, Wuhan, ChinaE-EL-H0108 and E-EL-M0048
Interleukin 6 antibodyProteintech, Wuhan, China21865-1-AP
Interleukin 6 kitElabscience, Wuhan, ChinaE-EL-H6156 and E-EL-M0044
Interleukin 15 antibodyAffinity Biosciences Ltd., Wuhan, ChinaDF2521
Interleukin 15 kitElabscience, Wuhan, ChinaE-EL-H0222 and E-EL-M0728 
Malondialdehyde kitElabscience, Wuhan, ChinaE-EL-0060
MHC antibodyAffinity Biosciences Ltd., Wuhan, ChinaDF8558
Optical microscopeZEISSPrimo Star
Paraffin slicerThermo scientificHM325
Pathological scanning software3DHISTECH (Hungary)Slide Viewer2.5.0
Penicillin-synthroid solutionBiosharp, Beijing, ChinaBL505A
Rabbit IgG Beyotime Biotechnology, Shanghai, ChinaA7016
ROS assay kitBeyotime Biotechnology, Shanghai, ChinaS0033M
Superoxide dismutase 1 antibodyProteintech, Wuhan, China10269-1-AP
Tissue embedder Wuhan Junjie Electronics Co., Ltd., Wuhan ChinaJB-P5
Tissue hydroextractorThermo scientificSTP420 ES
Total RNA isolation kitForegene, Chengdu, ChinaRE-03014
Total superoxide dismutase kitElabscience, Wuhan, ChinaE-BC-K020-M
White vasolineShanghai Aladdin Biochemical Technology Co., Ltd., Shanghai, ChinaP434227

References

  1. Li XQ, et al. Burden of alopecia areata in China, 1990-2021: Global Burden of Disease Study 2021. Chin Med J (Engl). 2025;138:318-324.
  2. Rodríguez-Tamez G, Maskan-Bermudez N, Tosti A. Alopecia areata incognita: Current evidence. Dermatol Ther (Heidelb). 2025;15:635-645.
  3. Zhou J, et al. Global burden of alopecia areata and associated diseases: A trend analysis from 1990 to 2021. J Cosmet Dermatol. 2025;24:e70076.
  4. Jeon JJ, Lee S, Kim MS, Kim YS, Hong SH, Yon DK, et al. The burden of alopecia areata among United States, 2000-2021: A systematic analysis for the global burden of disease study 2021. J Am Acad Dermatol. 2025;S0190-9622(25)02673-8.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Amygdalin TherapyC3H/HeJ MiceReactive Oxygen SpeciesSuperoxide DismutaseGlutathione PeroxidaseWestern BlotInflammatory Response